Pages that link to "Q35123511"

The following pages link to Glycobiology of neuromuscular disorders (Q35123511):

Displaying 40 items.

• Walker-Warburg syndrome (Q21203042) (← links)
• Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies (Q28256756) (← links)
• A Method to Produce and Purify Full-Length Recombinant Alpha Dystroglycan: Analysis of N- and O-Linked Monosaccharide Composition in CHO Cells with or without LARGE Overexpression (Q28485391) (← links)
• Hair for brain trade-off, a metabolic bypass for encephalization (Q28654854) (← links)
• A putative Src homology 3 domain binding motif but not the C-terminal dystrophin WW domain binding motif is required for dystroglycan function in cellular polarity in Drosophila (Q30158028) (← links)
• Altered expression of natively glycosylated alpha dystroglycan in pediatric solid tumors (Q33774186) (← links)
• Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscle (Q33784310) (← links)
• The dystroglycanopathies: the new disorders of O-linked glycosylation (Q33813487) (← links)
• Genetic defects in the human glycome (Q34534962) (← links)
• The twisted gene encodes Drosophila protein O-mannosyltransferase 2 and genetically interacts with the rotated abdomen gene encoding Drosophila protein O-mannosyltransferase 1. (Q34587283) (← links)
• Mutational and functional analysis of Large in a novel CHO glycosylation mutant (Q34983110) (← links)
• Reduced sialylation impacts ventricular repolarization by modulating specific K+ channel isoforms distinctly (Q35048797) (← links)
• Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice (Q35083466) (← links)
• Synthetic, structural, and biosynthetic studies of an unusual phospho-glycopeptide derived from α-dystroglycan (Q35222634) (← links)
• The role of defective glycosylation in congenital muscular dystrophy (Q35824015) (← links)
• Pitfalls and drawbacks in screening of congenital disorders of glycosylation (Q35839112) (← links)
• Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A. (Q35928246) (← links)
• Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage (Q36577280) (← links)
• Processing and assembly of the dystrophin glycoprotein complex (Q36726710) (← links)
• Congenital muscular dystrophies involving the O-mannose pathway (Q36855555) (← links)
• Sialic acids in human health and disease (Q36908164) (← links)
• The diversity of O-linked glycans expressed during Drosophila melanogaster development reflects stage- and tissue-specific requirements for cell signaling (Q36949362) (← links)
• Combining results from lectin affinity chromatography and glycocapture approaches substantially improves the coverage of the glycoproteome (Q37080677) (← links)
• Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. (Q37090108) (← links)
• Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives (Q37528083) (← links)
• Implications for the mammalian sialidases in the physiopathology of skeletal muscle (Q38056789) (← links)
• The Lec23 Chinese hamster ovary mutant is a sensitive host for detecting mutations in alpha-glucosidase I that give rise to congenital disorder of glycosylation IIb (CDG IIb). (Q38336319) (← links)
• The nutritional role of free sialic acid, a human milk monosaccharide, and its application as a functional food ingredient (Q38538651) (← links)
• Biological roles of glycans (Q38936714) (← links)
• CT-GalNAc transferase overexpression in adult mice is associated with extrasynaptic utrophin in skeletal muscle fibres (Q39668010) (← links)
• Distinct contributions of Galgt1 and Galgt2 to carbohydrate expression and function at the mouse neuromuscular junction (Q41267697) (← links)
• Thermodynamic and structural studies of carbohydrate binding by the agrin-G3 domain (Q41302311) (← links)
• A novel and simple method of production and biophysical characterization of a mini‐membrane protein, Ost4p: A Subunit of yeast oligosaccharyl transferase (Q42175817) (← links)
• Overelaborated synaptic architecture and reduced synaptomatrix glycosylation in a Drosophila classic galactosemia disease model (Q43056311) (← links)
• Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations. (Q44769590) (← links)
• Expression of the sialyltransferase, ST3Gal4, impacts cardiac voltage-gated sodium channel activity, refractory period and ventricular conduction (Q46133792) (← links)
• Genes required for functional glycosylation of dystroglycan are conserved in zebrafish (Q46480449) (← links)
• Lissencephaly type II. (Q48914638) (← links)
• Immunodetection of partially glycosylated isoforms of alpha-dystroglycan by a new monoclonal antibody against its beta-dystroglycan-binding epitope. (Q49158961) (← links)
• Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle System (Q51246043) (← links)